US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NeOnc Technologies Holdings

7.83

-1.6100-17.06%

Post-market: 7.830.00000.00%16:10 EST

Volume:61.00K

Turnover:534.77K

Market Cap:152.48M

PE:-2.95

High:9.81

Open:9.55

Low:7.71

Close:9.44

52wk High:25.00

52wk Low:3.20

Shares:19.47M

Float Shares:6.00M

Volume Ratio:0.92

T/O Rate:1.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6573

EPS(LYR):-0.6861

ROE:--

ROA:-853.56%

PB:-12.91

PE(LYR):-11.41

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

NeOnc Technologies Reports Promising Remission Results for Intranasal NEO100 in Recurrent IDH1-Mutant Astrocytoma

NeOnc Technologies Reports Promising Remission Rates in Phase 2 Trial of Intranasal NEO100 for Recurrent IDH1-Mutant Gliomas

NeOnc Technologies Unveils AI-Driven Study Showing Ultrasound Boosts NEO100 Potency Against Brain Tumors

NeOnc Technologies Unveils AI-Driven Study Showing Ultrasound Boosts NEO100 Potency Against Brain Tumors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NTHI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTHI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":7.83,"timestamp":1766005200000,"preClose":9.44,"halted":0,"volume":60995,"hourTrading":{"tag":"盘后","latestPrice":7.83,"preClose":7.83,"latestTime":"16:10 EST","volume":1,"amount":7.83,"timestamp":1766005804806},"delay":0,"floatShares":6000000,"shares":19474303,"eps":-2.657286,"marketStatus":"Closed","change":-1.61,"latestTime":"12-17 16:00:00 EST","open":9.55,"high":9.81,"low":7.71,"amount":534765.3755,"amplitude":0.222458,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.657286,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":5,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":9.44,"preHourTrading":{"tag":"盘前","latestPrice":9.5,"preClose":9.44,"latestTime":"09:29 EST","volume":400,"amount":3800,"timestamp":1765981771054},"postHourTrading":{"tag":"盘后","latestPrice":7.83,"preClose":7.83,"latestTime":"16:10 EST","volume":1,"amount":7.83,"timestamp":1766005804806},"volumeRatio":0.917508},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","floatShares":6000000,"roa":"-853.56%","roe":"--","lyrEps":-0.686076,"volumeRatio":0.917508,"shares":19474303,"dividePrice":0,"high":9.81,"amplitude":0.222458,"preClose":9.44,"low":7.71,"week52Low":3.2,"pbRate":"-12.91","psRate":"2541.82","week52High":25,"institutionHeld":0,"latestPrice":7.83,"eps":-2.657286,"divideRate":0,"volume":60995,"delay":0,"ttmEps":-2.657286,"open":9.55,"prevYearClose":25,"prevWeekClose":10.21,"prevMonthClose":8.95,"prevQuarterClose":9.08,"fiveDayClose":9.45,"twentyDayClose":7.06,"sixtyDayClose":11.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTHI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"NTHI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-18","symbol":"NTHI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1755489600000,"reportTimeType":"","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTHI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTHI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTHI","date":"2025-12-16","current":-2.946615,"percent":0.431694,"low":-26.074295,"twenty":-5.409591,"median":-3.570116,"eighty":-2.24376,"high":-1.357276,"avg":-4.958393,"sd":4.280209,"marketCap":192406113},"quantilePoints":[{"date":"2024-03-28","current":-18.899455,"twenty":-18.899455,"median":-18.899455,"eighty":-18.899455,"marketCap":282000000},{"date":"2025-03-28","current":-18.905834,"twenty":-19.009816,"median":-18.905834,"eighty":-18.902007,"marketCap":224950380},{"date":"2025-04-04","current":-15.093157,"twenty":-20.260752,"median":-18.902645,"eighty":-16.151884,"marketCap":179585386},{"date":"2025-04-11","current":-14.179375,"twenty":-19.504518,"median":-17.739974,"eighty":-15.124667,"marketCap":168712785},{"date":"2025-04-17","current":-11.028403,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"marketCap":131221055},{"date":"2025-04-25","current":-9.437162,"twenty":-18.904558,"median":-14.667776,"eighty":-10.965384,"marketCap":112287731},{"date":"2025-05-02","current":-8.444606,"twenty":-18.667559,"median":-12.525115,"eighty":-9.437162,"marketCap":100477836},{"date":"2025-05-09","current":-10.398208,"twenty":-17.342951,"median":-11.028403,"eighty":-9.33318,"marketCap":123722709},{"date":"2025-05-16","current":-2.933338,"twenty":-15.682389,"median":-10.398208,"eighty":-8.444606,"marketCap":137753858},{"date":"2025-05-23","current":-2.969802,"twenty":-15.348385,"median":-9.44504,"eighty":-3.015179,"marketCap":139466268},{"date":"2025-05-30","current":-2.99006,"twenty":-15.171931,"median":-9.437162,"eighty":-2.969802,"marketCap":140417606},{"date":"2025-06-06","current":-3.034627,"twenty":-15.093157,"median":-9.311123,"eighty":-2.969802,"marketCap":142510552},{"date":"2025-06-13","current":-2.593006,"twenty":-14.242395,"median":-8.476116,"eighty":-2.937389,"marketCap":121771366},{"date":"2025-06-20","current":-1.928548,"twenty":-14.191979,"median":-7.853798,"eighty":-2.929004,"marketCap":90567453},{"date":"2025-06-27","current":-1.616577,"twenty":-12.855967,"median":-3.034627,"eighty":-2.802066,"marketCap":75916836},{"date":"2025-07-03","current":-2.362066,"twenty":-12.222621,"median":-3.010317,"eighty":-2.532985,"marketCap":110926104},{"date":"2025-07-11","current":-1.977167,"twenty":-11.425425,"median":-2.998163,"eighty":-2.362066,"marketCap":92850666},{"date":"2025-07-18","current":-1.786743,"twenty":-11.028403,"median":-2.99006,"eighty":-2.222692,"marketCap":83908082},{"date":"2025-07-25","current":-1.904238,"twenty":-10.981139,"median":-2.959854,"eighty":-1.949616,"marketCap":89425847},{"date":"2025-08-01","current":-1.98527,"twenty":-10.618776,"median":-2.937389,"eighty":-1.970684,"marketCap":93231202},{"date":"2025-08-08","current":-1.944754,"twenty":-10.133526,"median":-2.931642,"eighty":-1.939892,"marketCap":91328524},{"date":"2025-08-15","current":-2.102765,"twenty":-9.654579,"median":-2.909028,"eighty":-1.943134,"marketCap":98748967},{"date":"2025-08-22","current":-2.604584,"twenty":-9.443464,"median":-2.799635,"eighty":-1.954478,"marketCap":110548110},{"date":"2025-08-29","current":-3.15078,"twenty":-9.437162,"median":-2.795584,"eighty":-1.970684,"marketCap":133730643},{"date":"2025-09-05","current":-3.371966,"twenty":-9.437162,"median":-2.876616,"eighty":-1.980408,"marketCap":143118611},{"date":"2025-09-12","current":-4.405675,"twenty":-9.43086,"median":-2.918386,"eighty":-1.98527,"marketCap":186992991},{"date":"2025-09-19","current":-5.457439,"twenty":-9.377293,"median":-2.933338,"eighty":-1.993373,"marketCap":231633736},{"date":"2025-09-26","current":-4.681029,"twenty":-9.292217,"median":-2.939656,"eighty":-2.005528,"marketCap":198680053},{"date":"2025-10-03","current":-5.141458,"twenty":-8.961365,"median":-2.969802,"eighty":-2.008769,"marketCap":218222354},{"date":"2025-10-10","current":-5.407785,"twenty":-8.482417,"median":-2.99006,"eighty":-2.016872,"marketCap":229526233},{"date":"2025-10-17","current":-4.730683,"twenty":-8.444606,"median":-3.002214,"eighty":-2.039561,"marketCap":200787556},{"date":"2025-10-24","current":-3.769199,"twenty":-7.97196,"median":-3.022472,"eighty":-2.067922,"marketCap":159978635},{"date":"2025-10-31","current":-4.590749,"twenty":-7.105442,"median":-3.15078,"eighty":-2.071973,"marketCap":194848230},{"date":"2025-11-07","current":-4.446301,"twenty":-6.304447,"median":-3.298614,"eighty":-2.085748,"marketCap":188717312},{"date":"2025-11-14","current":-4.053582,"twenty":-5.457439,"median":-3.638293,"eighty":-2.120592,"marketCap":172048879},{"date":"2025-11-21","current":-2.32457,"twenty":-5.457439,"median":-3.482559,"eighty":-2.150574,"marketCap":113613569},{"date":"2025-11-28","current":-3.566132,"twenty":-5.449314,"median":-3.447134,"eighty":-2.162729,"marketCap":174295011},{"date":"2025-12-05","current":-3.725512,"twenty":-5.41591,"median":-3.522302,"eighty":-2.193521,"marketCap":182084733},{"date":"2025-12-12","current":-3.733481,"twenty":-5.411396,"median":-3.568124,"eighty":-2.214589,"marketCap":182474219},{"date":"2025-12-16","current":-3.936691,"twenty":-5.409591,"median":-3.570116,"eighty":-2.24376,"marketCap":192406113}],"updateTime":1766010538539},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTHI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592943982","title":"NeOnc Technologies Reports Promising Remission Results for Intranasal NEO100 in Recurrent IDH1-Mutant Astrocytoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2592943982","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592943982?lang=en_us&edition=fundamental","pubTime":"2025-12-18 05:06","pubTimestamp":1766005585,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings Inc. has announced updated clinical results from its ongoing Phase 1/2a and compassionate-use experience evaluating intranasal NEO100 in patients with recurrent WHO Grade III/IV IDH1-mutant astrocytoma. The expanded clinical cohort now includes 25 patients, with updated results showing that intranasal NEO100 has resulted in radiographic remission in 6 of 25 patients (24%). This response rate is higher than the 8% typically reported with salvage therapies for recurrent high-grade gliomas. No significant toxicity has been observed with intranasal administration of NEO100, even with prolonged dosing. The updated clinical results were presented in the company's announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or lega","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL2wLqZ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"2591644953","title":"NeOnc Technologies Reports Promising Remission Rates in Phase 2 Trial of Intranasal NEO100 for Recurrent IDH1-Mutant Gliomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2591644953","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591644953?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:00","pubTimestamp":1765807246,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings Inc. has announced updated clinical results from its ongoing Phase 1/2a and compassionate-use clinical experience evaluating intranasal NEO100 in patients with recurrent WHO Grade III/IV IDH1-mutant astrocytoma. The expanded clinical cohort now includes 25 patients, with results indicating significant radiographic remission in 6 of 25 patients (24%), which is higher than the 8% response rate typically reported with salvage therapies in recurrent high-grade gliomas. No significant toxicity has been observed with intranasal administration of NEO100, even with prolonged dosing. These updated results have already been presented by the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neonc Technologies Hol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL1KM3sP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","BK4112","NTHI","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014039.USD","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014005.SGD","BK4007","SG9999014021.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ"],"gpt_icon":0},{"id":"2589848365","title":"NeOnc Technologies Unveils AI-Driven Study Showing Ultrasound Boosts NEO100 Potency Against Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2589848365","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589848365?lang=en_us&edition=fundamental","pubTime":"2025-12-06 06:01","pubTimestamp":1764972089,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings Inc.  announced newly published preclinical findings from a research collaboration at the University of Southern California. The study, now available on bioRxiv, indicates that the use of ultrasound enhances the therapeutic potency of NEO100 in treating primary and metastatic brain tumors. The research utilized an AI-driven, 3D-bioprinted methodology to rapidly generate patient-derived tumor organoids and demonstrated strong antitumor effects when NEO100 was combined with ultrasound. The results have already been presented through publication on bioRxiv.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neonc Technologies Holdings Inc. published the original content used to generate this news brief via EDGAR, t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL60Dbs4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"2588618773","title":"NeOnc Technologies Unveils AI-Driven Study Showing Ultrasound Boosts NEO100 Potency Against Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588618773","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588618773?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:00","pubTimestamp":1764597613,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings Inc.  announced newly published preclinical findings from a research collaboration at the University of Southern California  demonstrating that ultrasound enhances the potency of NEO100 in treating primary and metastatic brain tumors. The study, available on bioRxiv, utilized an AI-driven, 3D-bioprinted platform to identify NEO100 as a promising agent for sonodynamic therapy. Validation studies on patient-derived tumor organoids showed increased antitumor activity when NEO100 was combined with focused ultrasound. The company indicated that these results support advancing NEO100 with focused ultrasound into future clinical trials across various brain tumor types. Results have already been presented in the published preclinical study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL8CvNwn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","LU2095319765.USD","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","NTHI","BK4588","NDAQ","IE00BGHQF748.EUR","BK4007","LU2210149790.SGD"],"gpt_icon":0}],"pageSize":4,"totalPage":19,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NTHI\",params:#limit:6,delay:false,,,undefined,":[]}}